Number of cases | ||
---|---|---|
Sex | Male | 10 |
Female | 8 | |
Age | 20~39 years | 9 |
40~59 years | 7 | |
60~79 years | 2 | |
Underlying disease | Cerebral palsy | 10 |
Congenital brain damage | 3 | |
Brain malformation | 2 | |
CNS infection sequelae | 1 | |
Other | 2 |
case | sex | age | height | weight | BSA | CCr | CCr-eGFR | Cr | Cr-eGFR | cysC | cysC-eGFR | β2MG | β2MG-eGFR | Alb |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(y) | (cm) | (kg) | (m2) | (ml/m/1.73m2) | (mg/dL) | (ml/m/1.73m2) | (mg/L) | (ml/m/1.73m2) | (mg/) | (ml/m/1.73m2) | (g/dL) | |||
1 | M | 20 | 158.0 | 34.4 | 1.27 | 154.3 | 117.9 | 0.35 | 258.9 | 0.64 | 143.3 | 0.9 | 174.7 | 4.2 |
2 | M | 21 | 160.0 | 34.4 | 1.28 | 186.5 | 142.5 | 0.43 | 203.8 | 0.77 | 116.8 | 1.4 | 115.6 | 4.5 |
3 | M | 30 | 142.0 | 37.8 | 1.22 | 143.8 | 109.9 | 0.41 | 193.9 | 0.84 | 102.1 | 1.8 | 91.9 | 3.9 |
4 | M | 31 | 151.5 | 33.9 | 1.22 | 100.2 | 76.6 | 0.29 | 280.5 | 0.94 | 89.8 | 1.7 | 96.8 | 4.5 |
5 | M | 36 | 155.0 | 38.2 | 1.31 | 107.2 | 81.9 | 0.51 | 144.9 | 1.12 | 72.2 | 2.2 | 76.9 | 4.5 |
6 | M | 48 | 151.0 | 48.1 | 1.42 | 109.1 | 83.4 | 0.50 | 136.3 | 0.76 | 105.5 | 1.6 | 102.3 | 4.0 |
7 | M | 49 | 150.0 | 37.4 | 1.27 | 122.3 | 93.5 | 0.61 | 109.0 | 1.03 | 74.9 | 1.9 | 87.6 | 3.9 |
8 | M | 50 | 148.0 | 27.9 | 1.11 | 83.6 | 63.9 | 0.60 | 110.4 | 1.14 | 66.5 | 2.2 | 76.9 | 3.9 |
9 | M | 52 | 145.0 | 31.9 | 1.15 | 50.1 | 38.3 | 0.64 | 101.7 | 1.09 | 69.3 | 2.5 | 68.8 | 3.4 |
10 | M | 60 | 186.0 | 61.2 | 1.82 | 90.1 | 68.8 | 0.47 | 136.8 | 0.97 | 76.3 | 2.7 | 64.3 | 3.1 |
11 | F | 26 | 156.2 | 40.0 | 1.34 | 127.3 | 97.3 | 0.32 | 195.8 | 0.56 | 149.2 | 0.9 | 174.7 | 4.4 |
12 | F | 37 | 148.0 | 40.5 | 1.30 | 126.2 | 96.4 | 0.48 | 113.5 | 0.79 | 97.9 | 1.4 | 115.6 | 4.1 |
13 | F | 39 | 129.0 | 34.7 | 1.10 | 81.8 | 62.5 | 0.51 | 104.6 | 1.15 | 63.7 | 3.0 | 58.8 | 3.7 |
14 | F | 40 | 141.0 | 31.3 | 1.12 | 221.6 | 69.3 | 0.17 | 345.6 | 0.67 | 115.8 | 1.3 | 123.8 | 4.1 |
15 | F | 50 | 164.5 | 57.5 | 1.63 | 70.0 | 53.5 | 0.38 | 134.4 | 0.87 | 83.1 | 2.4 | 71.2 | 3.3 |
16 | F | 72 | 143.5 | 39.5 | 1.25 | 105.3 | 80.5 | 0.31 | 151.3 | 0.76 | 87.8 | 2.1 | 80.1 | 3.3 |
17 | F | 55 | 148.0 | 39.8 | 1.29 | 105.7 | 80.7 | 0.30 | 169.4 | 0.81 | 88.1 | 1.4 | 115.6 | 3.9 |
18 | F | 35 | 140.0 | 30.4 | 1.10 | 255.9 | 195.5 | 0.35 | 163.0 | 0.53 | 152.4 | 1.2 | 133.3 | 3.2 |
ME (mL/min/1.73 m2) (95% CI) | RMSE (mL/min/1.73 m2) | P30 (%) | |
---|---|---|---|
eGFR-Cr | 74.5 (−12.1 to 192.2) | 92.3 | 16.7 |
eGFR-cysC | 2.3 (−49.1 to 43.1) | 25.7 | 77.8 |
eGFR-Β2MG | 6.5 (−55.1 to 68.7) | 33.4 | 72.2 |